EMH Schweizerischer Ärzteverlag AG
Farnsburgerstrasse 8
CH-4132 Muttenz
+41 (0)61 467 85 44
support@swisshealthweb.ch
www.swisshealthweb.ch
Published on 19.09.2018
The new electronic ESC Textbook of Cardiovascular Medicine
Table 1: CardioMed table of contents. | |
Part 1: Introduction to the cardiovascular system | |
Section 1 Cardiovascular history and physical examination | Nicholas Boon |
Section 2 Developmental biology of the heart | Miguel Torres |
Section 3 Functional anatomy of the heart | Yen Ho |
Section 4 Cardiovascular physiology | Guido Grassi |
Section 5 Cardiovascular pharmacology | Faiez Zannad |
Section 6 Anticoagulation | Raffaele DeCaterina |
Section 7 Epidemiology and global burden | Sumeet Chugh |
Part 2: Investigations | |
Section 8 Electrocardiogram | Antonio Bayes de Luna |
Section 9 Chest radiography | Christian Herold |
Section 10 Cardiac ultrasound | Frank Flachskampf |
Section 11 Cardiovascular magnetic resonance | Dudley Pennell |
Section 12 Cardiovascular computed tomography | Stephan Achenbach |
Section 13 Nuclear cardiology and positron emission tomography | Philipp Kaufman |
Section 14 Invasive imaging – haemodynamics | Carlo di Mario |
Section 15 Selection of imaging techniques | Jeroen Bax |
Part 3: Heart diseases | |
Section 16 Genetics of CV diseases | Heribert Schunkert |
Section 17 Congenital heart disease (GUCH) | John E. Deanfield |
Section 18 Prevention in cardiovascular disease and rehabilitation | Massimo Piepoli |
Section 19 Diabetes mellitus metabolics syndrome | Lars Ryden |
Section 20 Heart and the brain | Hans-Christoph Diener |
Section 21 Cardiovascular problems in chronic kidney disease | Christoph Wanner |
Section 22 Erectile dysfunction | Charalambos Vlachopoulos |
Section 23 Lung disease | Martin Cowie |
Section 24 Gastrointestinal disease | Gerhard Rogler |
Section 25 Rheumatoid arthritis and the heart | Thomas F. Lüscher |
Section 26 Rheumatic heart disease | Ferande Peters |
Section 27 Cardio-oncology | John Groarke |
Section 28 HIV | Nombulelo Magula |
Section 29 Acute coronary syndromes | Stefan James |
Section 30 Takotsubo syndrome | Christian Templin |
Section 31 Chronic ischaemic heart disease | William Wjins |
Section 32 Myocardial disease | Perry Elliott |
Section 33 Pericardial disease | Yehuda Adler |
Section 34 Tumours of the heart | Gaetano Thiene |
Section 35 Valvular heart disease | Helmut Baumgartner |
Section 36 Infective endocarditis | Gilbert Habib |
Section 37 Heart failure | John McMurray, Thomas Lüscher |
Section 38 Bradycardia | Giuseppe Boriani |
Section 39 Syncope | Michele Brignole |
Section 40 Supraventricular tachycardias | Carina Blomström-Lundqvist |
Section 41 Atrial fibrillation | John A. Camm |
Section 42 Ventricular tachycardia | Brian Olshansky |
Section 43 Sudden cardiac death | Gerhard Hindricks |
Part 4: Vascular disease | |
Section 44 Systemic hypertension | Bryan Williams |
Section 45 Pulmonary hypertension | Marc Humbert |
Section 46 Diseases of the aorta | Raimund Erbel |
Section 47 Trauma to the cardiovascular system | Christoph Nienaber |
Section 48 Non-cardiac surgery | Steen Kristensen |
Section 49 Peripheral arterial diseases | Victor Aboyans |
Section 50 Venous thromboembolism | Stavros Konstantinides |
Section 51 Venous disease | Sebastien Schellong |
Part 5: Specific populations – gender and race | |
Section 52 Cardiovascular disease in women | Noel Bairey Merz |
Section 53 Pregnancy and heart disease | Vera Regitz-Zagrosek |
Section 54 Ethnicity | Gregory Lip |
Part 6 Other aspects | |
Section 55 Sports and heart disease | Antonio Pelliccia |
Section 56 Elderly | Franz H. Messerli and Tomasz Grodzicki |
Section 57 Precision medicine | Paulus Kirchhof |
Section 58 Decision-making and the heart team | Patrick W. Serruys |
Section 59 Psychological factors and heart disease | Susanne Pedersen |
Section 60 Interpretation of clinical trials | John Cleland |
Section 61 Environment | Thomas Münzel |
Section 62 Occupational and regulatory aspects | Demos Katritsis |
Section 63 Economics and cost-effectiveness | Lorenzo Mantovani |
Part 7: Appendices | |
Appendix 1 Cardiovascular disease risk estimation | |
Appendix 2 Patient reported outcome measures |
Published under the copyright license.
"Attribution - Non-Commercial - NoDerivatives 4.0"
No commercial reuse without permission.
See: emh.ch/en/emh/rights-and-licences/